Metropolis Healthcare IPO

F&O stock update for May expiry: Page Industries, Concor, Dixon, Metropolis, Crompton Greaves and Zydus Life have seen notable long buildup in recent days. Here's a short-term outlook on the stocks.

Barring Dr Lal Pathlabs, the other four healthcare related stocks listed below seem to be trapped in a range for now, charts suggest.

Metropolis Healthcare on Friday said its net profit declined 29.69 per cent to Rs 41.2 crore for the third quarter ended December 31, 2021. The diagnostics chain had reported a net profit of Rs 58.6 core in the same period of previous fiscal. Revenues, however, increased to Rs 293.1 crore in the period under review as against Rs 274.7 crore in the same period of 2020-21 fiscal, Metropolis Healthcare said in a statement. "We have been able to grow our non-COVID revenue despite a sharp drop in volumes from a government contract. We have made increased investments in digital and marketing, manpower & customer experience initiatives in order to strengthen our brand. This has impacted margins which we believe is a short-term phenomenon," Metropolis Healthcare Promoter and Managing Director Ameera Shah noted. The company has been able to successfully complete the acquisition of Hitech Diagnostics during the third quarter which will enable it to scale up business, improve the B2C revenue

Nanosafe Solutions is a startup of FITT (Foundation for Innovation and Technology Transfer) at IIT Delhi.

These six companies are currently valued at Rs 6,272 crore, 19 per cent higher than the Rs 5,275 crore they collectively raised via IPOs

On Tuesday, Metropolis Healthcare raised Rs 530 crore by selling shares to anchor investors.

The offering comprises secondary sale of 13.68 million shares, constituting of 27.3 per cent stake